Whether adolescent IgA nephropathy affects life expectancy varies greatly among individuals, mainly related to the severity of the disease and complications. The milder part of the patients will not affect the life expectancy, and if there are more complications, the life expectancy may be affected.
IgA nephropathy is a glomerular disease in which IgA or IgA deposits predominate in the glomerular mesangial area.IgA nephropathy has an insidious onset and is often manifested as asymptomatic hematuria with or without proteinuria, which is often detected during physical examination. Some patients have precursor symptoms such as upper respiratory tract or gastrointestinal tract infections a few hours or days before the onset of the disease, which are mainly manifested as episodic hematuria.
Whether adolescent IgA nephropathy affects life expectancy varies widely among individuals. Generally speaking, patients with mild disease and fewer complications have a better prognosis after active treatment, and their life expectancy will not be affected.
More severe disease such as the development of persistent uncontrollable proteinuria, hypertension, renal insufficiency. As well as patients with renal biopsy pathology showing tubular atrophy, glomerulosclerosis, or diffuse crescent formation, the prognosis is relatively poor and may affect life expectancy.
Adolescent IgA nephropathy patients should go to the hospital in time for consultation and timely treatment under the guidance of professional physicians.